Longboard Pharmaceuticals, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.44 | -$0.44 | -$0.44 |
Q2 2024 | 5 | -$0.60 | -$0.54 | -$0.58 |
Q3 2024 | 3 | -$0.62 | -$0.62 | -$0.62 |
Q1 2025 | 4 | -$0.67 | -$0.67 | -$0.67 |
Q2 2025 | 4 | -$0.69 | -$0.69 | -$0.69 |
Q3 2025 | 4 | -$0.69 | -$0.69 | -$0.69 |
Q4 2025 | 4 | -$0.70 | -$0.70 | -$0.70 |
Longboard Pharmaceuticals, Inc. Earnings Date And Information
Longboard Pharmaceuticals, Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.56 earnings per share for the quarter, missing analysts' consensus estimates of $-0.46 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Longboard Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.39 diluted earnings per share) and currently has a price-to-earnings ratio of -20.02. Longboard Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 31st, 2024 based on prior year's report dates.
Longboard Pharmaceuticals, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/01/2024 | Q2 2024 | -$0.46 | -$0.56 | -0.1 | $0 | $0 |
05/02/2024 | Q1 2024 | -$0.48 | -$0.42 | 0.06 | $0 | |
03/12/2024 | Q4 2023 | -$0.60 | -$0.63 | -0.03 | $8,000 | |
11/02/2023 | Q3 2023 | -$0.72 | -$0.55 | 0.17 | $0 | |
08/03/2023 | Q2 2023 | -$0.61 | -$0.65 | -0.04 | $0 | |
05/09/2023 | Q1 2023 | -$0.59 | -$0.54 | 0.05 | $0 | |
03/02/2023 | Q4 2022 | -$0.64 | $0 | |||
11/03/2022 | Q3 2022 | -$0.51 | -$0.66 | -0.15 | $0 | |
08/04/2022 | Q2 2022 | -$0.54 | -$0.67 | -0.13 | $0 | |
05/05/2022 | Q1 2022 | -$0.52 | -$0.56 | -0.04 | $0 | |
03/03/2022 | Q4 2021 | -$0.52 | $0 | |||
11/04/2021 | Q3 2021 | -$0.48 | -$0.38 | 0.1 | $0 | |
08/09/2021 | Q2 2021 | -$0.67 | -$0.41 | 0.26 | $0 | |
05/10/2021 | Q1 2021 | -$0.94 | -$0.84 | 0.1 | $0 | |
12/30/2020 | Q4 2020 | -$0.60 | $0 | |||
09/29/2020 | Q3 2020 | -$0.15 | $0 | |||
06/29/2020 | Q2 2020 | -$0.09 | $0 | |||
03/30/2020 | Q1 2020 | -$0.01 | $0 |
Longboard Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Longboard Pharmaceuticals, Inc.'s earnings date?
Longboard Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 31st, 2024 based off last year's report dates.
-
How can I listen to Longboard Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Longboard Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Longboard Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Longboard Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Longboard Pharmaceuticals, Inc. generate each year?
Longboard Pharmaceuticals, Inc. (:LBPH) has a recorded net income of $0. Longboard Pharmaceuticals, Inc. has generated $-2.39 earnings per share over the last four quarters.
-
What is Longboard Pharmaceuticals, Inc.'s price-to-earnings ratio?
Longboard Pharmaceuticals, Inc. (:LBPH) has a price-to-earnings ratio of -20.02 and price/earnings-to-growth ratio is -4.19.